[Skip to Content]
[Skip to Content Landing]
Correspondence
July 1, 2005

Incorporating the Results of the Ocular Hypertension Treatment Study Into Clinical Practice

Michael A. Kass, MD; Mae O. Gordon, PhD; Steven M. Kymes, PhD; et al Ocular Hypertension Treatment Study
Author Affiliations
 

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Ophthalmol. 2005;123(7):1021-1022. doi:10.1001/archopht.123.7.1021-b

We congratulate Robin et al1 and Jampel2 on their thought-provoking editorials. Commentaries such as these will stimulate debate and further research, which, in turn, will influence medical treatment and public policy.

The major question raised in both editorials is how to incorporate the results of the Ocular Hypertension Treatment Study (OHTS) into clinical practice.3,4 The authors correctly emphasize that only a minority of ocular hypertensive individuals develop open-angle glaucoma and that even a smaller fraction develop visual impairment or blindness. On this basis, Robin et al1 conclude that there is little reason to treat individuals with ocular hypertension, and they recommend careful follow-up and initiation of treatment after glaucomatous damage is confirmed.

×